Advertisement
Commentary| Volume 90, P16-18, August 2021

Download started.

Ok

Consumer-led screening for atrial fibrillation: What is the next step?

Published:June 10, 2021DOI:https://doi.org/10.1016/j.ejim.2021.05.030
Consumer-led screening for atrial fibrillation: What is the next step?
Previous ArticleCombining New Classes of Drugs for HFrEF: from Trials to Clinical Practice
Next ArticleLung ultrasound in COVID-19: Insights from the frontline and research experiences
      Atrial fibrillation (AF) is increasingly prevalent in the general population and is associated with significant morbidity and mortality. Opportunistic screening for AF is now a class I indication in the most recent 2020 guidelines from the European Society of Cardiology (
      • Hindrickx G.
      • Potpara T.
      • Dagres N.
      • Arbelo E.
      • Bax J.J.
      • Blomstrom-Ludqvist C.
      • Boriani G.
      • Castella M.
      • Da G.A.
      • Dilaveris P.E.
      • Fauchier L.
      • Filippatos G.
      • Kalman J.M.
      • La Meir M.
      • Lane D.A.
      • Lebeau J.P.
      • Lettino M.
      • Lip G.Y.H.
      • Pinto F.J.
      • Thomas G.N.
      • Valgimigli M.
      • Van Gelder I.C.
      • Van Putte B.P.
      • Watkins C.L
      2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for cardio-thoracic surgery (EACTS).
      Eur Heart J. 2020; 42: 373-798
      ). Systematic ECG screening should also be considered to detect AF in individuals aged >75 years, or those at high risk for stroke.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to European Journal of Internal Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Hindrickx G.
        • Potpara T.
        • Dagres N.
        • Arbelo E.
        • Bax J.J.
        • Blomstrom-Ludqvist C.
        • Boriani G.
        • Castella M.
        • Da G.A.
        • Dilaveris P.E.
        • Fauchier L.
        • Filippatos G.
        • Kalman J.M.
        • La Meir M.
        • Lane D.A.
        • Lebeau J.P.
        • Lettino M.
        • Lip G.Y.H.
        • Pinto F.J.
        • Thomas G.N.
        • Valgimigli M.
        • Van Gelder I.C.
        • Van Putte B.P.
        • Watkins C.L
        2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for cardio-thoracic surgery (EACTS).
        Eur Heart J. 2020; 42: 373-798
        View in Article
        • Lowres N.
        • Olivier J.
        • Chao T.F.
        • Chen S.A.
        • Chen Y.
        • Diederichsen A.
        • Fitzmaurice D.A.
        • Gomez-Doblas J.J.
        • Harbison J.
        • Healey J.S.
        • Hobbs F.D.R.
        • Kaasenbrood F.
        • Keen W.
        • Lee V.W.
        • Lindholt J.S.
        • Lip G.Y.H.
        • Mairesse G.H.
        • Mant J.
        • Martin J.W.
        • Martin-Rioboo E.
        • McManus D.D.
        • Muniz J.
        • Munzel T.
        • Nakamya J.
        • Neubeck L.
        • Orchard J.J.
        • Perula de Torres L.
        • Proietti M.
        • Quinn F.R.
        • Roalfe A.K.
        • Sandhu R.K.
        • Schnabel R.B.
        • Smyth B.
        • Soni A.
        • Tieleman R.
        • Wang J.
        • Wild P.S.
        • Yan B.P.
        • Freedman B
        Estimated stroke risk, yield, and number needed to screen for atrial fibrillation detected through single time screening: a multicountry patient-level meta-analysis of 141,220 screened individuals.
        PLoS Med. 2019; 16e1002903
        View in Article
        • Mairesse G.H.
        • Moran P.
        • Van Gelder I.C.
        • Elsner C.
        • Rosenqvist M.
        • Mant J.
        • Banerjee A.
        • Gorenek B.
        • Brachmann J.
        • Varma N.
        • Glotz de Lima G.
        • Kalman J.
        • Claes N.
        • Lobban T.
        • Lane D.
        • Lip G.Y.H.
        • Boriani G
        Screening for atrial fibrillation: a European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS) and Societa Latinoaméricana de Estimulation cardiac y electrophysiologia (SOLAECE).
        Europace. 2017; 19: 1589-1623
        View in Article
        • Freedman B.
        • Camm A.J.
        • Calkins H.
        • Healey J.
        • Rosenqvist M.
        • Wang J.
        • Albert C.
        • Anderson C.
        • Antoniou S.
        • Benjamin E.
        • Boriani G.
        • Brachmann J.
        • Brandes A.
        • Chao T.F.
        • Conen D.
        • Engdahl J.
        • Fauchier L.
        • Fitzmaurice D.
        • Friberg L.
        • Gersh B.
        • Gladstone D.
        • Glotzer T.
        • Gwynne K.
        • Hankey G.
        • Harbison J.
        • Hillis G.
        • True Hills M.
        • Kamel H.
        • Kirchhof P.
        • Kowey P.
        • Krieger D.
        • Lee V.
        • Levin L.A.
        • Lip G.Y.H.
        • Lobban T.
        • Lowres N.
        • Mairesse G.H.
        • Martinez C.
        • Neubeck L.
        • Orchard J.
        • Piccini J.
        • Poppe K.
        • Potpara T.
        • Puererfellner H.
        • Rienstra M.
        • Sandhu RK
        • Schnabel R.
        • Siu C.W.
        • Steinhubl S.
        • Svendsen J.
        • Svennberg E.
        • Themistoclakis S.
        • Tieleman R.
        • Turakhia M.
        • Tveit A.
        • Uittenbogaart S.
        • Van Gelder I.
        • Varma A.
        • Wachter R.
        • Yan B
        Screening for atrial fibrillation: a report of the AF-screen international collaboration.
        Circulation. 2017; 135: 1851-1867
        View in Article
        • Arnar D.O.
        • Mairesse G.H.
        • Boriani G.
        • Calkins H.
        • Chin A.
        • Coats A.
        • Deharo J.C.
        • Svendsen J.H.
        • Heidbuchel H.
        • Isa R.
        • Kalman J.M.
        • Lane D.A.
        • Louw R.
        • Lip G.Y.H.
        • Maury P.
        • Potpara T.
        • Sacher F.
        • Sanders P.
        • Varma N.
        • Fauchier L.
        Management of asymptomatic arrhythmias: a European Heart Rhythm Association (EHRA) consensus document, endorsed by the Heart Failure Association (HFA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), Cardiac Arrhythmias Society of Southern Africa (CASSA), and Latin America Heart Rhythm Society (LAHRS).
        Europace. 2019; https://doi.org/10.1093/Europace/euz046
        View in Article

      6. Svennberg E. Benefits of systematic screening for atrial fibrillation – the STROKESTOP study. 2021. EHRA congress on line /late breaking trials. 2021.

        View in Article
        • Wegner F.K.
        • Hochhauser S.
        • Ellermann C.
        • Lange P.S.
        • Frommeyer G.
        • Leitz P.
        • Eckart L.
        • Decering D.G.
        Prospective blinded evaluation oft he smartphone-based AliveCor Kardia ECG monitor for atrial fibrillation detection: the PEAK-AF study.
        Eur J Int Med. 2020; https://doi.org/10.1061/j.ejim/2019.11.018
        View in Article
        • Perez M.V.
        • Mahaffey K.W.
        • Hedlin H.
        • Rumsfeld J.S.
        • Garcia A.
        • Ferris T.
        • Balasubramanian V.
        • Russo A.M.
        • Rajmane A.
        • Cheung L.
        • Hung G.
        • Lee J
        • et al.
        for the Apple Haert Study investigators. Large-scale assessment of a smartwatch to identify atrial fibrillation.
        NEJM. 2019; 318: 1909-1917
        View in Article
        • Guo Y.
        • Wang H.
        • Zhang H.
        • Liu T.
        • Liang Z.
        • Xia Y.
        • Yan L.
        • Xing Y.
        • Shi H.
        • Li S.
        • Liu Y.
        • Liu F.
        • Feng M.
        • Chen Y.
        Lip GYH on behalf of the mAFA II investigators. Mobile photoplethysmographic technology to detect atrial fibrillation.
        J An Coll Cardiol. 2019; 74: 2365-2375
        View in Article
        • Boriani G.
        • Schnabel R.
        • Healey J.
        • Lopez R.D.
        • Verbiest-van Gurp N.
        • Lobban T.
        • Camm A.J.
        • Freedman B.
        Consumer-led screening for atrial fibrillation using consumer-facing wearables, devices and apps: a survey of health care professionnales by AF-SCREEN international collaboration.
        Eur J Int Med. 2020; 82: 97-104
        View in Article
        • Van Gelder I.C.
        • Healey J.S.
        • Crijns H.J.G.M.
        • Wang J.
        • Hohhnloser S.H.
        • Gold M.R.
        • Capucci A.
        • Lau C.P.
        • Morillo C.A.
        • Hobbelt A.H.
        • Rienstra M.
        • Connolly S.J.
        Duration of device-detected subclinical atrial fibrillation and occurrence of stroke in ASSERT.
        Eur Heart J. 2017; 38: 1339-1344
        View in Article
        • Mairesse G.H.
        Subclinical atrial fibrillation duration should be incorporated in the clinical assessment of stroke risk during atrial fibrillation screening.
        Open Access J Cardiol. 2020; https://doi.org/10.23880/oajc-16000150
        View in Article
        • Lopes R.D.
        • Alings M.
        • Connolly S.J.
        • Beresh H.
        • Granger C.B.
        • Mazuecos J.B.
        • Boriani G.
        • Nielsen J.C.
        • Conen D.
        • Hohnloser S.H.
        • Mairesse G.H.
        • Mabo P.
        • Camm A.J.
        • Healey J.S.
        Rationale and design of the Apixaban for the reduction of thrombo-embolism in patients with device-detected sub-clinical atrial fibrillation (ARTESIA) trial.
        Am Heart J. 2017; 189: 137-145
        View in Article
        • Kirchhof P.
        • Blank B.F.
        • Calvet M.
        • Camm A.J.
        • Chlouverakis G.
        • Diener H.C.
        • Goette A.
        • Huening A.
        • Lip G.Y.H.
        • Simantirakis E.
        • Vardas P.
        Probing oral anticoagulation in patients with atrial high rate episodes: rationale and design of the Non-vitamin K antagonist oral anticoagulants in patients with atrial high rate episodes (NOAH-AFNET 6) trial.
        Am Heart J. 2017; 190: 12-18
        View in Article
        • Lip G.Y.H.
        The ABC pathway: an integrated approach to improve AF management.
        Nat Rev Cardiol. 2017; 14: 627-628
        View in Article
        • Guo Y.
        • Lane D.A.
        • Wang I.
        • Zhang H.
        • Wang H.
        • Zhang W.
        • Wen J.
        • Xing Y.
        • Wu F.
        • Xia Y.
        • Liu T.
        • Wu F.
        • Liang Z.
        • Liu F.
        • Zhoa Y.
        • Li R.
        • Zhang L.
        • Guo J.
        • Burnside G.
        • Chen Y.
        Lip GYH for the mAF-App II trial investigators. Mobile health technology to improve care for patients with atrial fibrillation.
        J Am Coll Cardiol. 2020; 75: 1523-1534
        View in Article
        • Guo Y.
        • Guo J.
        • Shi X.
        • Yao Y.
        • Sun Y.
        • Xia Y.
        • Yu B.
        • Liu T.
        • Chen Y.
        Lip GYH on behalf of the mAFA II trial investigators. Mobile health technology-supported atrial fibrillation screening and integrated care: a report from the mAFA-II trial Long-term Extension Cohort.
        Eur J Int Med. 2020; 82: 105-111
        View in Article

      Article info

      Publication history

      Published online: June 10, 2021
      Accepted: May 16, 2021
      Received: May 9, 2021

      Identification

      DOI: https://doi.org/10.1016/j.ejim.2021.05.030

      Copyright

      © 2021 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.

      ScienceDirect

      Access this article on ScienceDirect
      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.


      RELX